Racial Disparities Revealed In Prostate Cancer SurgeryBlack prostate cancer patients may not be getting the same quality of care as white patients, according to a first-of-its-kind study by researchers at Henry Ford Hospital who found racial disparities in the results of surgery to remove diseased prostates...
Avoiding Repeat Biopsies In Prostate Cancer - MDxHealth Launches ConfirmMDx Each year, in the United States, more than 650,000 men receive a negative prostate biopsy result, with around 25-35% of these results being false negative. However, a new prostate cancer test has been launched by MdxHealth. The test - ConfirmMDx™ for Prostate Cancer - will help physicians identify which men have a true-negative prostate biopsy from those who may have occult cancer...
Ancient Remedy Slows Prostate Tumor Cell ProliferationAn over-the-counter natural remedy derived from honeybee hives arrests the growth of prostate cancer cells and tumors in mice, according to a new paper from researchers at the University of Chicago Medicine. Caffeic acid phenethyl ester, or CAPE, is a compound isolated from honeybee hive propolis, the resin used by bees to patch up holes in hives...
Prostate Cancer Stem Cells Identified Among Low-PSA CellsProstate cancer cells that defy treatment and display heightened tumor-generating capacity can be identified by levels of prostate specific antigen (PSA) expressed in the tumor cells, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in Cell Stem Cell...
Gay Men And Minorities Have Poorer Quality Of Life After Prostate Cancer TreatmentTo improve the quality of life in gay men and minorities treated for prostate cancer, a greater awareness of ethnic and sexual preference-related factors is needed to help men choose a more-suitable treatment plan, researchers from Thomas Jefferson University Hospital conclude in a literature review published in Nature Reviews Urology...
Boron-Nitride Nanotubes Show Potential In Cancer TreatmentA new study has shown that adding boron-nitride nanotubes to the surface of cancer cells can double the effectiveness of Irreversible Electroporation, a minimally invasive treatment for soft tissue tumors in the liver, lung, prostate, head and neck, kidney and pancreas. Although this research is in the very early stages, it could one day lead to better therapies for cancer...
Denosumab (Xgeva) Not Approved For Metastasis PreventionAmgen's application for expanded indications for denosumab (Xgeva) were turned down by the FDA (Food and Drug Administration) - the expanded indications were to include bone metastases prevention in patients with castration-resistant prostate cancer...